About
Andrew Winokur, PhD, MD, is affiliated with the Department of Psychiatry at UConn Health in Farmington, Connecticut. His publications, spanning from 1997 to 2022, focus on major depressive disorder and neurology, including clinical trials evaluating treatments such as esketamine nasal spray, ziprasidone, mirtazapine, fluoxetine, and nefazodone. His research addresses both mood symptoms and sleep physiology in depression. He has frequently collaborated with co-authors Allison Meisner, Bruce J. Albala, Daniel P. McNally, David A. Schoenfeld, and David J. Williamson.
